These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4330898)

  • 1. Conversion of angiotensin I to angiotensin II in the canine mesenteric circulation.
    DiSalvo J; Montefusco CB
    Am J Physiol; 1971 Dec; 221(6):1576-9. PubMed ID: 4330898
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of SQ 20881 and captopril on mesenteric, renal, and iliac vasculatures.
    Fiksen-Olsen MJ; Britton SL; Houck PC; Romero JC
    Am J Physiol; 1983 Mar; 244(3):H313-9. PubMed ID: 6187226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs.
    Aiken JW; Vane JR
    Circ Res; 1972 Mar; 30(3):263-73. PubMed ID: 4334163
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dehydration and cardiac tamponade on superior mesenteric artery flow: role of vasoactive substances.
    Adar R; Franklin A; Spark RF; Rosoff CB; Salzman EW
    Surgery; 1976 May; 79(5):534-43. PubMed ID: 1265661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme and bradykininase in the lung.
    Alabaster VA; Bakhle YS
    Circ Res; 1972 Sep; 31(9):Suppl 2:72-84. PubMed ID: 4341482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conversion of angiotensin I in the rat peripheral circulation].
    Kreye VA
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):379-80. PubMed ID: 4326419
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoactive peptides.
    Sander GE; Huggins CG
    Annu Rev Pharmacol; 1972; 12():227-64. PubMed ID: 4339018
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of nifedipine and TMB-8 on angiotensin II-induced mesenteric vasoconstriction in dogs.
    Takahara A; Yoshida K; Suzuki-Kusaba M; Hisa H; Satoh S
    Arch Int Pharmacodyn Ther; 1994; 328(3):288-96. PubMed ID: 7625883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of angiotensin III from [des-Asp1]angiotensin I in the mesentric vasculature.
    Sexton JM; Britton SL; Beierwaltes WH; Fiksen-Olsen MJ; Romero JC
    Am J Physiol; 1979 Aug; 237(2):H218-23. PubMed ID: 464116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
    Baron-Menguy C; Toutain B; Cousin M; Dumont O; Guihot AL; Vessières E; Subra JF; Custaud MA; Loufrani L; Henrion D
    Hypertens Res; 2010 Aug; 33(8):857-66. PubMed ID: 20535114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic and regional hemodynamics during treatment with angiotensin].
    Novelli GP; Frullani F; Ariano M; Pallini C; Pagni E
    Policlinico Prat; 1967 Nov; 74(48):1620-30. PubMed ID: 4304975
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
    Itoh T; Kajikuri J; Tada T; Suzuki Y; Mabuchi Y
    J Physiol; 2003 May; 548(Pt 3):893-906. PubMed ID: 12651915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme.
    Ferreira SH; Greene LH; Alabaster VA; Bakhle YS; Vane JR
    Nature; 1970 Jan; 225(5230):379-80. PubMed ID: 4312128
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
    Cousin M; Custaud MA; Baron-Menguy C; Toutain B; Dumont O; Guihot AL; Vessières E; Subra JF; Henrion D; Loufrani L
    Hypertension; 2010 Jan; 55(1):109-15. PubMed ID: 19948989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conversion of angiotensin I to angiotensin II in vivo.
    Ng KK; Vane JR
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):188-9. PubMed ID: 4298591
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood.
    Oparil S; Sanders CA; Haber E
    Circ Res; 1970 May; 26(5):591-9. PubMed ID: 4315298
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenergic mechanisms in canine mesenteric circulation.
    Swan KG; Reynolds DG
    Am J Physiol; 1971 Jun; 220(6):1779-85. PubMed ID: 4397293
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II.
    Lu C; Su LY; Lee RM; Gao YJ
    Eur J Pharmacol; 2010 May; 634(1-3):107-12. PubMed ID: 20156432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.